Navigation Links
Gen-Probe Reports Financial Results for the Fourth Quarter of 2011
Date:2/14/2012

our products, (ix) our dependence on a small number of customers, contract manufacturers and single source suppliers of raw materials, (x) changes in third-party reimbursement policies regarding our products could adversely affect sales, (xi) changes in government regulation or tax policy affecting our diagnostic products could harm our sales, increase our development costs or increase our taxes, (xii) the risk that our intellectual property may be infringed or invalidated, and (xiii) our involvement in patent and other intellectual property and commercial litigation could be expensive and could divert management's attention.  This list includes some, but not all, of the factors that could affect our ability to achieve results described in forward-looking statements.  For additional information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we file with the SEC, including our most recent annual report on Form 10-K and all subsequent periodic reports.  We assume no obligation and expressly disclaim any duty to update forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

Contact:Michael Watts
Vice president, investor relations and
corporate communications
858-410-8673

Gen-Probe IncorporatedConsolidated Balance Sheets - GAAP(In thousands, except share and per share data)December 31,December 31,20112010Assets(Unaudited)Current assets:Cash and cash equivalents, including restricted cash of $38 and $16 at December 31, 2011 and December 31, 2010, respectively

$  87,021$  59,690Marketable securities

218,789170,648Trade accounts receivable, net of allowance for doubtful accounts of $320 and $355 at December 31, 2011 and December 31, 2010, respectively

57,76754,739Accounts receivable — other

3,4465,493Inventories


'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Gen-Probe Reports Financial Results for the Second Quarter of 2011
2. Gen-Probe to Webcast Two Upcoming Investor Presentations
3. Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call
4. Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2010 Earnings Conference Call
6. Gen-Probe to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference
7. Gen-Probe Acquires GTI Diagnostics for $53 Million in Cash
8. Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
9. Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
10. Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
11. Gen-Probe to Webcast Four Upcoming Investor Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... Jan. 15, 2014   Niagara Thermal Products is ... Buffalo BioBlower Technologies LLC ("B3") as the critical thermal ... award from the Army Corps of Engineers.  B3 has ... all biological contaminants and destroys VOCs and other chemical ...
(Date:1/15/2014)... OXFORD, England and SAN JOSE, California ... an international biotechnology company developing antibody-drug conjugates for cancer, today ... its Board of Directors. Dr Reynolds has over 20 years, ... Chief Medical Officer at Seattle Genetics. "I am ...
(Date:1/15/2014)... A study has been launched to test ... track could help to tackle the problem of obesity.  This ... GP surgery based in Stowmarket) and academics at University Campus ... Telemetry technology, which is inspired by equipment used to collect ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... May 14 Memory Pharmaceuticals,Corp. (Nasdaq: MEMY ... first,quarter ended March 31, 2008., "We had ... with,our collaborations and refocusing our operations to advance ... Chief Executive Officer.,"Roche,s recent decision to license R3487/MEM ...
... Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that ... from the U.K. Medicines and Healthcare,products Regulatory ... (CTA),to begin a Phase II clinical trial ... paclitaxel and carboplatin in patients with,advanced head ...
... China Sky One,Medical, Inc. (OTC Bulletin Board: CSKI; ... marketer and distributor of pharmaceutical,medicinal and diagnostic products, ... were made in conjunction with the Company,filing an ... Stock Exchange., As of May 7, 2008, ...
Cached Biology Technology:Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 2Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 3Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 4Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 5Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 6Memory Pharmaceuticals Reports First Quarter 2008 Financial Results 7Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2China Sky One Medical, Inc. Changes Management Team 2China Sky One Medical, Inc. Changes Management Team 3
(Date:4/17/2014)... France have hit on a novel method to ... correct and most effective treatment possible., Kidney stones ... and developing world. If left untreated, apart from ... failure and other complications. In many patients treated ... a more effective pathological approach to diagnosis and ...
(Date:4/17/2014)... Current Biology on April 17 have discovered ... Brazilian insects, which represent four distinct but related species ... example of an animal with sex-reversed genitalia. , ... animals, Neotrogla is the only example in ... Yoshizawa from Hokkaido University in Japan. , During copulation, ...
(Date:4/17/2014)... at the University of Texas Medical Branch at ... women treated with radiation for cervical cancer should ... , The UTMB researchers, finding a high ... survivors treated with radiation, offer new recommendations that ... cancer screening about eight years after their initial ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2
... People with high cholesterol in their early 40s are ... low cholesterol, according to research that will be presented ... Annual Meeting in Chicago, April 1219, 2008. "Our ... and patients to attack high cholesterol levels in their,40s ...
... antioxidants as a way to improve health by filling ... studies found no evidence that the nutrition supplements extend ... could increase risk for death. The reviewers want ... researcher with the U.S. Department of Agriculture said that ...
... Fla. University of Florida researchers have identified a gene ... the physical effects of mental stress to the point ... Searching for the presence of this gene may be one ... risk for the phenomenon, said David S. Sheps, M.D., a ...
Cached Biology News:Antioxidant users don't live longer, analysis of studies concludes 2Antioxidant users don't live longer, analysis of studies concludes 3Mental stress reduces blood flow to the heart in patients with gene variation 2Mental stress reduces blood flow to the heart in patients with gene variation 3
Naked1 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Rabbit polyclonal to Phosphothreonine-X-Phosphotyrosine (HRP) ( Abpromise for all tested applications)....
Anti-ADAMTS-4, disintegrin-like domain Immunogen: Synthetic peptide - KLH conjugated Available Date: 38569...
Leucine-rich repeat-containing G-protein coupled receptor 4...
Biology Products: